Ciba Health
Ciba Health is a digital health solution that combines root-cause medicine, physician-led care teams, and AI to prevent and reverse chronic diseases. The company offers a personalized approach to healthcare, focusing on treating the underlying causes of conditions such as type 2 diabetes, obesity, and autoimmune disorders. With a strong emphasis on clinical rigor and outcomes, Ciba Health has demonstrated significant reductions in medication use and hospitalizations among its patients. The platform is designed for a wide range of clients, including consumers, employers, and health plans, positioning itself as a leader in the digital therapeutics space.
Ciba Health
Ciba Health is a digital health solution that combines root-cause medicine, physician-led care teams, and AI to prevent and reverse chronic diseases. The company offers a personalized approach to healthcare, focusing on treating the underlying causes of conditions such as type 2 diabetes, obesity, and autoimmune disorders. With a strong emphasis on clinical rigor and outcomes, Ciba Health has demonstrated significant reductions in medication use and hospitalizations among its patients. The platform is designed for a wide range of clients, including consumers, employers, and health plans, positioning itself as a leader in the digital therapeutics space.
TL;DR
Founded: 2019
Headquarters: New York
Focus: AI-powered root-cause chronic care (T2 diabetes, obesity, autoimmune, digestive, mental health)
Business model: Virtual multidisciplinary care for consumers, employers, and health plans
Latest disclosed funding: $10M Series A (May 2024) led by DigiTx Partners
Company Overview
Problem Domain
Chronic disease prevention and reversal; digital therapeutics and virtual chronic care
Founded
2019
Industry
Digital health / Digital therapeutics
Funding Track Record
$10M
Company announcement of oversubscribed Series A with participation from E12 Ventures, 3CC Capital, Plug and Play Ventures and angel investors.
Investor Signal
“Led by DigiTx Partners with participation from E12 Ventures, 3CC Capital, Plug and Play Ventures and angel investors”